{
  "claim_id": "claim_005",
  "claim": "Flublok (quadrivalent) was evaluated in the pivotal trial against Fluarix (quadrivalent standard-dose vaccine).",
  "document": {
    "pdf_name": "Liu_et_al.__2024_",
    "source_pdf": "data/clinical_files/Liu et al. (2024).pdf",
    "total_pages": 13,
    "total_blocks": 124,
    "total_characters": 39807
  },
  "extraction_result": {
    "success": true,
    "total_snippets_found": 4,
    "error": null
  },
  "extracted_evidence": [
    {
      "id": 1,
      "quote": "sera pre- and post vaccination with quad rival ent in activated egg based (IIV4), cell culture based (ccIIV4), and recombinant (RIV4) influenza vaccines were collected from healthcare personnel (18-64 years) in 2018 19 (N = 723) and 2019 20 (N = 684) influenza seasons.",
      "relevance_explanation": "This quote shows that the study evaluated quadrivalent recombinant (RIV4, i.e., Flublok), egg-based (IIV4, which includes Fluarix), and cell culture-based (ccIIV4) vaccines, indicating a direct comparison among these vaccines."
    },
    {
      "id": 2,
      "quote": "Fluarix IIV4 n=120 18-44 years: n=55 45-64 years: n=65 Completed day 0 (n=120) 1 month (n=118) and 6 months (n=107) visit",
      "relevance_explanation": "This quote identifies Fluarix IIV4 as one of the quadrivalent standard-dose vaccines used in the trial, supporting that Flublok (RIV4) was evaluated against Fluarix (IIV4)."
    },
    {
      "id": 3,
      "quote": "a recombinant influenza vaccine (Flublok Quad rival ent by SanofiPasteur, RIV4). RIV4 contains 3 times the i d 45 HA/d / ...d",
      "relevance_explanation": "This quote explicitly identifies Flublok Quadrivalent (RIV4) as one of the vaccines evaluated in the study, confirming its inclusion in the pivotal trial."
    },
    {
      "id": 4,
      "quote": "n=318 (*139) IIV4-ccIIV4 n=106 (*51) IIV4-RIV4 n=104 (*44) IIV4-IIV4 n=103 (*41)",
      "relevance_explanation": "This quote lists the randomization arms, including IIV4-RIV4, which means participants received IIV4 (such as Fluarix) in one year and RIV4 (Flublok) in another, demonstrating a direct comparison between these vaccines."
    }
  ],
  "model_used": "gpt-4.1"
}